You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ALOSETRON HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for alosetron hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00067457 ↗ Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy Completed GlaxoSmithKline Phase 3 2003-06-01 The purpose of this study is to compare the safety and effectiveness of as needed versus fixed dosing of an investigational medication for women with severe diarrhea-predominant Irritable Bowel Syndrome (IBS) who have failed conventional therapy.
NCT00067561 ↗ Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy Completed GlaxoSmithKline Phase 3 2003-06-01 The purpose of this study is to compare the safety and effectiveness of different doses of an investigational medication in women with severe diarrhea-predominant Irritable Bowel Syndrome (IBS) who have failed conventional therapy.
NCT00130741 ↗ Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS) Completed Hadassah Medical Organization Phase 1 2005-07-01 This is an 8-week double-blind, placebo-controlled, randomized, parallel-group study with an additional two week baseline observation period to evaluate the safety of combination herbal therapy (CHT) versus placebo and short and long-term efficacy in terms of improved IBS, overall quality of life (QOL) and symptomatology.
NCT00370032 ↗ Study to Assess the Effect Of Alosetron On Mucosal Blood Flow Completed GlaxoSmithKline Phase 4 2006-12-01 This study will look at colonic mucosal blood flow in subjects who have taken alosetron vs placebo and healthy volunteers vs diarrhea-predominant Irritable Bowel Syndrome (d-IBS) patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for alosetron hydrochloride

Condition Name

Condition Name for alosetron hydrochloride
Intervention Trials
Irritable Colon 4
Irritable Bowel Syndrome (IBS) 2
Colonic Diseases, Functional 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for alosetron hydrochloride
Intervention Trials
Irritable Bowel Syndrome 5
Diarrhea 3
Syndrome 2
Colonic Diseases, Functional 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for alosetron hydrochloride

Trials by Country

Trials by Country for alosetron hydrochloride
Location Trials
United States 76
Australia 2
United Kingdom 1
Israel 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for alosetron hydrochloride
Location Trials
Connecticut 2
Wisconsin 2
Colorado 2
Washington 2
California 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for alosetron hydrochloride

Clinical Trial Phase

Clinical Trial Phase for alosetron hydrochloride
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
Phase 2 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for alosetron hydrochloride
Clinical Trial Phase Trials
Completed 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for alosetron hydrochloride

Sponsor Name

Sponsor Name for alosetron hydrochloride
Sponsor Trials
GlaxoSmithKline 4
Hadassah Medical Organization 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for alosetron hydrochloride
Sponsor Trials
Industry 4
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.